Document Detail


Lymphokine-activated killer traffic assay and our preliminary clinical results of regional arterial infusion of lymphokine-activated killer cells for renal cell carcinoma.
MedLine Citation:
PMID:  1949369     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In vivo distribution of radiolabeled lymphokine-activated killer (LAK) cells that were administered either through the caudal vein or the abdominal aorta of Lewis rats was studied. The LAK traffic study showed remarkable increase in radioactivity in several organs peripheral to the arterial injection site. We began treating the patients with metastatic renal cancer by means of regional arterial administration of LAK cells. This treatment was supported by the results of the traffic assay. Our regional LAK therapy, which involves a weekly leukapheresis in combination with daily systemic low dose interleukin-2 administration, has been in practice for over 2.5 years. Seven out of 12 metastatic lesions in the 7 patients treated showed regression. Two responding cases have been alive for over 2 years. Responding lesions were bone, muscle, para-aortic lymph node, and/or retroperitoneum. The regional arterial administration of LAK cells is local therapy. However, this mode of therapy could be useful for those patients with extrapulmonary nonresectable metastasis and at least one injectable feeding artery. This study shows our laboratory data concerning the localization of LAK cells transferred via arterial route and our clinical cases treated with regional arterial administration of LAK cells.
Authors:
M Hayakawa; Y Koyama; R D Williams; A Osawa
Related Documents :
8931829 - A prospective study of disease progression in patients with atherosclerotic renal arter...
21920339 - Correlation of angiographic late loss with neointimal proliferation in stents evaluated...
9787949 - Isolated iliac artery stenosis as a cause of kidney graft dysfunction post-transplant.
9509569 - Acute bilateral renal artery occlusion due to granulomatous and necrotizing vasculitis.
15306959 - Renal artery stenosis and a functioning hilar paraganglioma: a rare cause of renovascul...
19033249 - Assessment of renal vasoconstriction in vivo after intra-arterial administration of the...
1153689 - Pulmonary veno-occlusive disease.
2911089 - Mitral and tricuspid valve rupture from blunt trauma sustained during a motor vehicle c...
20028909 - Assessment of in-stent restenosis using 64-mdct: analysis of the core-64 multicenter in...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Urologia internationalis     Volume:  47 Suppl 1     ISSN:  0042-1138     ISO Abbreviation:  Urol. Int.     Publication Date:  1991  
Date Detail:
Created Date:  1991-11-29     Completed Date:  1991-11-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0417373     Medline TA:  Urol Int     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  127-31     Citation Subset:  IM    
Affiliation:
University of the Ryukyus, Okinawa, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Carcinoma, Renal Cell / therapy*
Humans
Immunotherapy, Adoptive*
Infusions, Intra-Arterial
Iodine Radioisotopes / diagnostic use
Kidney Neoplasms / therapy*
Killer Cells, Lymphokine-Activated / immunology*,  transplantation
Leukapheresis
Male
Middle Aged
Rats
Rats, Inbred Lew
Chemical
Reg. No./Substance:
0/Iodine Radioisotopes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical evaluation of adjuvant chemotherapy for high stage bladder cancer.
Next Document:  Antitumor effects of interleukin 2 against renal cell carcinoma: basic study and clinical applicatio...